nodes	percent_of_prediction	percent_of_DWPC	metapath
Plerixafor—CXCR4—Binding and entry of HIV virion—CCR5—atopic dermatitis	0.0527	0.107	CbGpPWpGaD
Plerixafor—CXCR4—Binding and entry of HIV virion—CD4—atopic dermatitis	0.0331	0.0669	CbGpPWpGaD
Plerixafor—CXCR4—Chemokine receptors bind chemokines—CCL22—atopic dermatitis	0.0222	0.0448	CbGpPWpGaD
Plerixafor—CXCR4—Chemokine receptors bind chemokines—CCL27—atopic dermatitis	0.0198	0.04	CbGpPWpGaD
Plerixafor—CXCR4—Early Phase of HIV Life Cycle—CCR5—atopic dermatitis	0.0194	0.0391	CbGpPWpGaD
Plerixafor—CXCR4—Chemokine receptors bind chemokines—CCL17—atopic dermatitis	0.0177	0.0358	CbGpPWpGaD
Plerixafor—CXCR4—Chemokine receptors bind chemokines—CCL11—atopic dermatitis	0.0143	0.0289	CbGpPWpGaD
Plerixafor—CXCR4—Hematopoietic Stem Cell Differentiation—IL5—atopic dermatitis	0.0126	0.0255	CbGpPWpGaD
Plerixafor—CXCR4—Early Phase of HIV Life Cycle—CD4—atopic dermatitis	0.0122	0.0246	CbGpPWpGaD
Plerixafor—CXCR4—Chemokine receptors bind chemokines—CCR3—atopic dermatitis	0.0117	0.0236	CbGpPWpGaD
Plerixafor—CXCR4—Syndecan-4-mediated signaling events—CCL5—atopic dermatitis	0.0111	0.0224	CbGpPWpGaD
Plerixafor—CXCR4—Chemokine receptors bind chemokines—CXCR3—atopic dermatitis	0.0102	0.0206	CbGpPWpGaD
Plerixafor—CXCR4—Peptide GPCRs—CCR3—atopic dermatitis	0.00933	0.0188	CbGpPWpGaD
Plerixafor—CXCR4—Peptide ligand-binding receptors—CCL22—atopic dermatitis	0.00835	0.0169	CbGpPWpGaD
Plerixafor—CXCR4—Chemokine receptors bind chemokines—CXCL10—atopic dermatitis	0.00824	0.0166	CbGpPWpGaD
Plerixafor—CXCR4—Peptide GPCRs—CXCR3—atopic dermatitis	0.00815	0.0165	CbGpPWpGaD
Plerixafor—CXCR4—Peptide ligand-binding receptors—CCL27—atopic dermatitis	0.00744	0.015	CbGpPWpGaD
Plerixafor—CXCR4—Chemokine receptors bind chemokines—CCL5—atopic dermatitis	0.00709	0.0143	CbGpPWpGaD
Plerixafor—CXCR4—Peptide ligand-binding receptors—CCL17—atopic dermatitis	0.00668	0.0135	CbGpPWpGaD
Plerixafor—CXCR4—Chemokine receptors bind chemokines—CCR5—atopic dermatitis	0.00639	0.0129	CbGpPWpGaD
Plerixafor—CXCR4—G alpha (i) signalling events—CCL27—atopic dermatitis	0.00628	0.0127	CbGpPWpGaD
Plerixafor—CXCR4—Class A/1 (Rhodopsin-like receptors)—CCL22—atopic dermatitis	0.0056	0.0113	CbGpPWpGaD
Plerixafor—CXCR4—Peptide ligand-binding receptors—CCL11—atopic dermatitis	0.00538	0.0109	CbGpPWpGaD
Plerixafor—CXCR4—Peptide GPCRs—CCR5—atopic dermatitis	0.00511	0.0103	CbGpPWpGaD
Plerixafor—CXCR4—Class A/1 (Rhodopsin-like receptors)—CCL27—atopic dermatitis	0.00499	0.0101	CbGpPWpGaD
Plerixafor—CXCR4—Hematopoietic Stem Cell Differentiation—IL1B—atopic dermatitis	0.00485	0.0098	CbGpPWpGaD
Plerixafor—CXCR4—Class A/1 (Rhodopsin-like receptors)—CCL17—atopic dermatitis	0.00448	0.00905	CbGpPWpGaD
Plerixafor—CXCR4—Peptide ligand-binding receptors—CCR3—atopic dermatitis	0.00439	0.00886	CbGpPWpGaD
Plerixafor—CXCR4—GPCR ligand binding—CCL22—atopic dermatitis	0.00427	0.00862	CbGpPWpGaD
Plerixafor—CXCR4—Peptide ligand-binding receptors—TAC1—atopic dermatitis	0.00391	0.0079	CbGpPWpGaD
Plerixafor—CXCR4—Peptide ligand-binding receptors—NPS—atopic dermatitis	0.00391	0.0079	CbGpPWpGaD
Plerixafor—CXCR4—Chemokine receptors bind chemokines—CXCL8—atopic dermatitis	0.00386	0.0078	CbGpPWpGaD
Plerixafor—CXCR4—Peptide ligand-binding receptors—CXCR3—atopic dermatitis	0.00383	0.00775	CbGpPWpGaD
Plerixafor—CXCR4—GPCR ligand binding—CCL27—atopic dermatitis	0.0038	0.00768	CbGpPWpGaD
Plerixafor—CXCR4—G alpha (i) signalling events—CCR3—atopic dermatitis	0.0037	0.00748	CbGpPWpGaD
Plerixafor—CXCR4—Class A/1 (Rhodopsin-like receptors)—CCL11—atopic dermatitis	0.00361	0.00729	CbGpPWpGaD
Plerixafor—CXCR4—GPCRs, Class A Rhodopsin-like—CCR3—atopic dermatitis	0.00343	0.00694	CbGpPWpGaD
Plerixafor—CXCR4—GPCR ligand binding—CCL17—atopic dermatitis	0.00341	0.00689	CbGpPWpGaD
Plerixafor—CXCR4—G alpha (i) signalling events—CXCR3—atopic dermatitis	0.00323	0.00654	CbGpPWpGaD
Plerixafor—CXCR4—HIV Life Cycle—CCR5—atopic dermatitis	0.00314	0.00635	CbGpPWpGaD
Plerixafor—CXCR4—Peptide ligand-binding receptors—CXCL10—atopic dermatitis	0.0031	0.00626	CbGpPWpGaD
Plerixafor—CXCR4—GPCRs, Class A Rhodopsin-like—CXCR3—atopic dermatitis	0.003	0.00606	CbGpPWpGaD
Plerixafor—CXCR4—Class A/1 (Rhodopsin-like receptors)—CCR3—atopic dermatitis	0.00294	0.00594	CbGpPWpGaD
Plerixafor—CXCR4—CXCR4-mediated signaling events—CD4—atopic dermatitis	0.0029	0.00586	CbGpPWpGaD
Plerixafor—CXCR4—Hematopoietic Stem Cell Differentiation—IL6—atopic dermatitis	0.00284	0.00574	CbGpPWpGaD
Plerixafor—CXCR4—GPCR ligand binding—CCL11—atopic dermatitis	0.00275	0.00555	CbGpPWpGaD
Plerixafor—CXCR4—Peptide ligand-binding receptors—CCL5—atopic dermatitis	0.00267	0.00539	CbGpPWpGaD
Plerixafor—CXCR4—Class A/1 (Rhodopsin-like receptors)—NPS—atopic dermatitis	0.00262	0.0053	CbGpPWpGaD
Plerixafor—CXCR4—Class A/1 (Rhodopsin-like receptors)—TAC1—atopic dermatitis	0.00262	0.0053	CbGpPWpGaD
Plerixafor—CXCR4—G alpha (i) signalling events—CXCL10—atopic dermatitis	0.00261	0.00528	CbGpPWpGaD
Plerixafor—CXCR4—Class A/1 (Rhodopsin-like receptors)—CXCR3—atopic dermatitis	0.00257	0.0052	CbGpPWpGaD
Plerixafor—CXCR4—Peptide ligand-binding receptors—CCR5—atopic dermatitis	0.0024	0.00486	CbGpPWpGaD
Plerixafor—CXCR4—G alpha (i) signalling events—CCL5—atopic dermatitis	0.00225	0.00455	CbGpPWpGaD
Plerixafor—CXCR4—GPCR ligand binding—CCR3—atopic dermatitis	0.00224	0.00453	CbGpPWpGaD
Plerixafor—CXCR4—Signaling by GPCR—CCL22—atopic dermatitis	0.00219	0.00442	CbGpPWpGaD
Plerixafor—CXCR4—HIV Infection—CCR5—atopic dermatitis	0.00217	0.00438	CbGpPWpGaD
Plerixafor—CXCR4—GPCR downstream signaling—CCL27—atopic dermatitis	0.00215	0.00434	CbGpPWpGaD
Plerixafor—CXCR4—Class A/1 (Rhodopsin-like receptors)—CXCL10—atopic dermatitis	0.00208	0.0042	CbGpPWpGaD
Plerixafor—CXCR4—G alpha (i) signalling events—CCR5—atopic dermatitis	0.00203	0.0041	CbGpPWpGaD
Plerixafor—CXCR4—GPCR ligand binding—NPS—atopic dermatitis	0.002	0.00403	CbGpPWpGaD
Plerixafor—CXCR4—GPCR ligand binding—TAC1—atopic dermatitis	0.002	0.00403	CbGpPWpGaD
Plerixafor—CXCR4—HIV Life Cycle—CD4—atopic dermatitis	0.00197	0.00398	CbGpPWpGaD
Plerixafor—CXCR4—GPCR ligand binding—CXCR3—atopic dermatitis	0.00196	0.00396	CbGpPWpGaD
Plerixafor—CXCR4—Signaling by GPCR—CCL27—atopic dermatitis	0.00195	0.00394	CbGpPWpGaD
Plerixafor—CXCR4—GPCRs, Class A Rhodopsin-like—CCR5—atopic dermatitis	0.00188	0.0038	CbGpPWpGaD
Plerixafor—CXCR4—Class A/1 (Rhodopsin-like receptors)—CCL5—atopic dermatitis	0.00179	0.00362	CbGpPWpGaD
Plerixafor—CXCR4—Signaling by GPCR—CCL17—atopic dermatitis	0.00175	0.00354	CbGpPWpGaD
Plerixafor—CXCR4—Class A/1 (Rhodopsin-like receptors)—CCR5—atopic dermatitis	0.00161	0.00326	CbGpPWpGaD
Plerixafor—CXCR4—GPCR ligand binding—CXCL10—atopic dermatitis	0.00158	0.0032	CbGpPWpGaD
Plerixafor—CXCR4—Disease—GLB1—atopic dermatitis	0.00157	0.00317	CbGpPWpGaD
Plerixafor—CXCR4—Peptide ligand-binding receptors—CXCL8—atopic dermatitis	0.00145	0.00294	CbGpPWpGaD
Plerixafor—CXCR4—Signaling by GPCR—CCL11—atopic dermatitis	0.00141	0.00285	CbGpPWpGaD
Plerixafor—CXCR4—Signaling Pathways—FCER2—atopic dermatitis	0.00139	0.00281	CbGpPWpGaD
Plerixafor—CXCR4—GPCR ligand binding—CCL5—atopic dermatitis	0.00136	0.00275	CbGpPWpGaD
Plerixafor—CXCR4—HIV Infection—CD4—atopic dermatitis	0.00136	0.00275	CbGpPWpGaD
Plerixafor—CXCR4—Signaling Pathways—CCL22—atopic dermatitis	0.00129	0.00261	CbGpPWpGaD
Plerixafor—CXCR4—GPCR downstream signaling—CCR3—atopic dermatitis	0.00127	0.00256	CbGpPWpGaD
Plerixafor—CXCR4—GPCR ligand binding—CCR5—atopic dermatitis	0.00123	0.00248	CbGpPWpGaD
Plerixafor—CXCR4—G alpha (i) signalling events—CXCL8—atopic dermatitis	0.00123	0.00248	CbGpPWpGaD
Plerixafor—CXCR4—Signaling Pathways—CCL27—atopic dermatitis	0.00115	0.00233	CbGpPWpGaD
Plerixafor—CXCR4—Signaling by GPCR—CCR3—atopic dermatitis	0.00115	0.00232	CbGpPWpGaD
Plerixafor—CXCR4—GPCR downstream signaling—TAC1—atopic dermatitis	0.00113	0.00228	CbGpPWpGaD
Plerixafor—CXCR4—GPCR downstream signaling—NPS—atopic dermatitis	0.00113	0.00228	CbGpPWpGaD
Plerixafor—CXCR4—GPCR downstream signaling—CXCR3—atopic dermatitis	0.00111	0.00224	CbGpPWpGaD
Plerixafor—CXCR4—Disease—SLC11A1—atopic dermatitis	0.00105	0.00213	CbGpPWpGaD
Plerixafor—CXCR4—GPCR downstream signaling—IL5—atopic dermatitis	0.00105	0.00212	CbGpPWpGaD
Plerixafor—CXCR4—Signaling Pathways—CCL17—atopic dermatitis	0.00103	0.00209	CbGpPWpGaD
Plerixafor—CXCR4—Signaling by GPCR—TAC1—atopic dermatitis	0.00102	0.00207	CbGpPWpGaD
Plerixafor—CXCR4—Signaling by GPCR—NPS—atopic dermatitis	0.00102	0.00207	CbGpPWpGaD
Plerixafor—Pain—Tacrolimus—atopic dermatitis	0.00101	0.00199	CcSEcCtD
Plerixafor—CXCR4—Signaling by GPCR—CXCR3—atopic dermatitis	0.00101	0.00203	CbGpPWpGaD
Plerixafor—Vomiting—Fluocinolone Acetonide—atopic dermatitis	0.000985	0.00195	CcSEcCtD
Plerixafor—Haemoglobin—Triamcinolone—atopic dermatitis	0.000978	0.00194	CcSEcCtD
Plerixafor—Rash—Fluocinolone Acetonide—atopic dermatitis	0.000976	0.00193	CcSEcCtD
Plerixafor—Haemoglobin—Methylprednisolone—atopic dermatitis	0.000976	0.00193	CcSEcCtD
Plerixafor—Dermatitis—Fluocinolone Acetonide—atopic dermatitis	0.000975	0.00193	CcSEcCtD
Plerixafor—CXCR4—Class A/1 (Rhodopsin-like receptors)—CXCL8—atopic dermatitis	0.000975	0.00197	CbGpPWpGaD
Plerixafor—Haemorrhage—Triamcinolone—atopic dermatitis	0.000973	0.00193	CcSEcCtD
Plerixafor—Haemorrhage—Methylprednisolone—atopic dermatitis	0.000971	0.00192	CcSEcCtD
Plerixafor—Headache—Fluocinolone Acetonide—atopic dermatitis	0.00097	0.00192	CcSEcCtD
Plerixafor—Feeling abnormal—Tacrolimus—atopic dermatitis	0.00097	0.00192	CcSEcCtD
Plerixafor—Abdominal distension—Prednisone—atopic dermatitis	0.000967	0.00191	CcSEcCtD
Plerixafor—Gastrointestinal pain—Tacrolimus—atopic dermatitis	0.000962	0.00191	CcSEcCtD
Plerixafor—Connective tissue disorder—Methylprednisolone—atopic dermatitis	0.000954	0.00189	CcSEcCtD
Plerixafor—CXCR4—Signaling by GPCR—IL5—atopic dermatitis	0.000953	0.00192	CbGpPWpGaD
Plerixafor—Vomiting—Mometasone—atopic dermatitis	0.00094	0.00186	CcSEcCtD
Plerixafor—Urticaria—Tacrolimus—atopic dermatitis	0.000935	0.00185	CcSEcCtD
Plerixafor—Immune system disorder—Hydrocortisone—atopic dermatitis	0.000933	0.00185	CcSEcCtD
Plerixafor—Rash—Mometasone—atopic dermatitis	0.000932	0.00185	CcSEcCtD
Plerixafor—Dermatitis—Mometasone—atopic dermatitis	0.000931	0.00184	CcSEcCtD
Plerixafor—Abdominal pain—Tacrolimus—atopic dermatitis	0.00093	0.00184	CcSEcCtD
Plerixafor—Headache—Mometasone—atopic dermatitis	0.000926	0.00183	CcSEcCtD
Plerixafor—CXCR4—Signaling Pathways—KIF3A—atopic dermatitis	0.000921	0.00186	CbGpPWpGaD
Plerixafor—Erythema—Prednisolone—atopic dermatitis	0.000921	0.00182	CcSEcCtD
Plerixafor—Nausea—Fluocinolone Acetonide—atopic dermatitis	0.00092	0.00182	CcSEcCtD
Plerixafor—Mental disorder—Hydrocortisone—atopic dermatitis	0.000905	0.00179	CcSEcCtD
Plerixafor—Erythema—Hydrocortisone—atopic dermatitis	0.0009	0.00178	CcSEcCtD
Plerixafor—CXCR4—GPCR downstream signaling—CXCL10—atopic dermatitis	0.000895	0.00181	CbGpPWpGaD
Plerixafor—Haemoglobin—Betamethasone—atopic dermatitis	0.000887	0.00176	CcSEcCtD
Plerixafor—Haemoglobin—Dexamethasone—atopic dermatitis	0.000887	0.00176	CcSEcCtD
Plerixafor—Haemorrhage—Betamethasone—atopic dermatitis	0.000883	0.00175	CcSEcCtD
Plerixafor—Haemorrhage—Dexamethasone—atopic dermatitis	0.000883	0.00175	CcSEcCtD
Plerixafor—Nausea—Mometasone—atopic dermatitis	0.000878	0.00174	CcSEcCtD
Plerixafor—Immune system disorder—Methylprednisolone—atopic dermatitis	0.000877	0.00174	CcSEcCtD
Plerixafor—Hypersensitivity—Tacrolimus—atopic dermatitis	0.000867	0.00172	CcSEcCtD
Plerixafor—Ill-defined disorder—Prednisolone—atopic dermatitis	0.000855	0.00169	CcSEcCtD
Plerixafor—Mental disorder—Methylprednisolone—atopic dermatitis	0.000851	0.00168	CcSEcCtD
Plerixafor—Erythema—Triamcinolone—atopic dermatitis	0.000847	0.00168	CcSEcCtD
Plerixafor—Erythema—Methylprednisolone—atopic dermatitis	0.000845	0.00167	CcSEcCtD
Plerixafor—Asthenia—Tacrolimus—atopic dermatitis	0.000844	0.00167	CcSEcCtD
Plerixafor—Ill-defined disorder—Hydrocortisone—atopic dermatitis	0.000835	0.00165	CcSEcCtD
Plerixafor—CXCR4—Signaling Pathways—CMA1—atopic dermatitis	0.000833	0.00168	CbGpPWpGaD
Plerixafor—CXCR4—Signaling Pathways—CCL11—atopic dermatitis	0.000833	0.00168	CbGpPWpGaD
Plerixafor—Pruritus—Tacrolimus—atopic dermatitis	0.000833	0.00165	CcSEcCtD
Plerixafor—Malaise—Prednisolone—atopic dermatitis	0.000831	0.00164	CcSEcCtD
Plerixafor—Syncope—Prednisolone—atopic dermatitis	0.000826	0.00164	CcSEcCtD
Plerixafor—CXCR4—Signaling by GPCR—CXCL10—atopic dermatitis	0.000812	0.00164	CbGpPWpGaD
Plerixafor—Malaise—Hydrocortisone—atopic dermatitis	0.000811	0.00161	CcSEcCtD
Plerixafor—Loss of consciousness—Prednisolone—atopic dermatitis	0.00081	0.0016	CcSEcCtD
Plerixafor—Syncope—Hydrocortisone—atopic dermatitis	0.000807	0.0016	CcSEcCtD
Plerixafor—Diarrhoea—Tacrolimus—atopic dermatitis	0.000805	0.00159	CcSEcCtD
Plerixafor—Loss of consciousness—Hydrocortisone—atopic dermatitis	0.000791	0.00157	CcSEcCtD
Plerixafor—Ill-defined disorder—Triamcinolone—atopic dermatitis	0.000786	0.00156	CcSEcCtD
Plerixafor—Ill-defined disorder—Methylprednisolone—atopic dermatitis	0.000784	0.00155	CcSEcCtD
Plerixafor—CXCR4—Signaling Pathways—STAT6—atopic dermatitis	0.000783	0.00158	CbGpPWpGaD
Plerixafor—Dizziness—Tacrolimus—atopic dermatitis	0.000778	0.00154	CcSEcCtD
Plerixafor—Discomfort—Prednisolone—atopic dermatitis	0.000775	0.00153	CcSEcCtD
Plerixafor—Haemoglobin—Prednisone—atopic dermatitis	0.000773	0.00153	CcSEcCtD
Plerixafor—CXCR4—GPCR downstream signaling—CCL5—atopic dermatitis	0.00077	0.00156	CbGpPWpGaD
Plerixafor—Haemorrhage—Prednisone—atopic dermatitis	0.000769	0.00152	CcSEcCtD
Plerixafor—Erythema—Betamethasone—atopic dermatitis	0.000769	0.00152	CcSEcCtD
Plerixafor—Erythema—Dexamethasone—atopic dermatitis	0.000769	0.00152	CcSEcCtD
Plerixafor—Malaise—Triamcinolone—atopic dermatitis	0.000764	0.00151	CcSEcCtD
Plerixafor—Malaise—Methylprednisolone—atopic dermatitis	0.000762	0.00151	CcSEcCtD
Plerixafor—Unspecified disorder of skin and subcutaneous tissue—Hydrocortisone—atopic dermatitis	0.000761	0.00151	CcSEcCtD
Plerixafor—Syncope—Triamcinolone—atopic dermatitis	0.00076	0.0015	CcSEcCtD
Plerixafor—Syncope—Methylprednisolone—atopic dermatitis	0.000758	0.0015	CcSEcCtD
Plerixafor—Discomfort—Hydrocortisone—atopic dermatitis	0.000757	0.0015	CcSEcCtD
Plerixafor—Connective tissue disorder—Prednisone—atopic dermatitis	0.000756	0.0015	CcSEcCtD
Plerixafor—Anaphylactic shock—Prednisolone—atopic dermatitis	0.000752	0.00149	CcSEcCtD
Plerixafor—Vomiting—Tacrolimus—atopic dermatitis	0.000748	0.00148	CcSEcCtD
Plerixafor—Loss of consciousness—Triamcinolone—atopic dermatitis	0.000744	0.00147	CcSEcCtD
Plerixafor—Loss of consciousness—Methylprednisolone—atopic dermatitis	0.000743	0.00147	CcSEcCtD
Plerixafor—CXCR4—GPCR ligand binding—CXCL8—atopic dermatitis	0.000742	0.0015	CbGpPWpGaD
Plerixafor—Rash—Tacrolimus—atopic dermatitis	0.000742	0.00147	CcSEcCtD
Plerixafor—Dermatitis—Tacrolimus—atopic dermatitis	0.000741	0.00147	CcSEcCtD
Plerixafor—Shock—Prednisolone—atopic dermatitis	0.00074	0.00146	CcSEcCtD
Plerixafor—Headache—Tacrolimus—atopic dermatitis	0.000737	0.00146	CcSEcCtD
Plerixafor—Anaphylactic shock—Hydrocortisone—atopic dermatitis	0.000734	0.00145	CcSEcCtD
Plerixafor—Hyperhidrosis—Prednisolone—atopic dermatitis	0.000727	0.00144	CcSEcCtD
Plerixafor—Shock—Hydrocortisone—atopic dermatitis	0.000722	0.00143	CcSEcCtD
Plerixafor—Nervous system disorder—Hydrocortisone—atopic dermatitis	0.00072	0.00143	CcSEcCtD
Plerixafor—Arthralgia—Methylprednisolone—atopic dermatitis	0.000719	0.00142	CcSEcCtD
Plerixafor—Unspecified disorder of skin and subcutaneous tissue—Methylprednisolone—atopic dermatitis	0.000715	0.00141	CcSEcCtD
Plerixafor—Skin disorder—Hydrocortisone—atopic dermatitis	0.000713	0.00141	CcSEcCtD
Plerixafor—Ill-defined disorder—Betamethasone—atopic dermatitis	0.000713	0.00141	CcSEcCtD
Plerixafor—Ill-defined disorder—Dexamethasone—atopic dermatitis	0.000713	0.00141	CcSEcCtD
Plerixafor—Discomfort—Triamcinolone—atopic dermatitis	0.000712	0.00141	CcSEcCtD
Plerixafor—Discomfort—Methylprednisolone—atopic dermatitis	0.000711	0.00141	CcSEcCtD
Plerixafor—Hyperhidrosis—Hydrocortisone—atopic dermatitis	0.00071	0.00141	CcSEcCtD
Plerixafor—Dry mouth—Triamcinolone—atopic dermatitis	0.000705	0.0014	CcSEcCtD
Plerixafor—CXCR4—Signaling by GPCR—CCL5—atopic dermatitis	0.000699	0.00141	CbGpPWpGaD
Plerixafor—Nausea—Tacrolimus—atopic dermatitis	0.000699	0.00138	CcSEcCtD
Plerixafor—Immune system disorder—Prednisone—atopic dermatitis	0.000694	0.00138	CcSEcCtD
Plerixafor—CXCR4—GPCR downstream signaling—CCR5—atopic dermatitis	0.000694	0.0014	CbGpPWpGaD
Plerixafor—Malaise—Betamethasone—atopic dermatitis	0.000693	0.00137	CcSEcCtD
Plerixafor—Malaise—Dexamethasone—atopic dermatitis	0.000693	0.00137	CcSEcCtD
Plerixafor—Anaphylactic shock—Triamcinolone—atopic dermatitis	0.000691	0.00137	CcSEcCtD
Plerixafor—Anaphylactic shock—Methylprednisolone—atopic dermatitis	0.00069	0.00137	CcSEcCtD
Plerixafor—Syncope—Dexamethasone—atopic dermatitis	0.000689	0.00136	CcSEcCtD
Plerixafor—Syncope—Betamethasone—atopic dermatitis	0.000689	0.00136	CcSEcCtD
Plerixafor—Shock—Triamcinolone—atopic dermatitis	0.00068	0.00135	CcSEcCtD
Plerixafor—Insomnia—Prednisolone—atopic dermatitis	0.00068	0.00135	CcSEcCtD
Plerixafor—CXCR4—Signaling Pathways—CCR3—atopic dermatitis	0.000679	0.00137	CbGpPWpGaD
Plerixafor—Shock—Methylprednisolone—atopic dermatitis	0.000679	0.00134	CcSEcCtD
Plerixafor—Nervous system disorder—Methylprednisolone—atopic dermatitis	0.000676	0.00134	CcSEcCtD
Plerixafor—Loss of consciousness—Dexamethasone—atopic dermatitis	0.000675	0.00134	CcSEcCtD
Plerixafor—Loss of consciousness—Betamethasone—atopic dermatitis	0.000675	0.00134	CcSEcCtD
Plerixafor—Paraesthesia—Prednisolone—atopic dermatitis	0.000675	0.00134	CcSEcCtD
Plerixafor—Mental disorder—Prednisone—atopic dermatitis	0.000674	0.00133	CcSEcCtD
Plerixafor—Skin disorder—Methylprednisolone—atopic dermatitis	0.00067	0.00133	CcSEcCtD
Plerixafor—Erythema—Prednisone—atopic dermatitis	0.000669	0.00133	CcSEcCtD
Plerixafor—Musculoskeletal discomfort—Hydrocortisone—atopic dermatitis	0.000669	0.00132	CcSEcCtD
Plerixafor—Hyperhidrosis—Triamcinolone—atopic dermatitis	0.000668	0.00132	CcSEcCtD
Plerixafor—Hyperhidrosis—Methylprednisolone—atopic dermatitis	0.000667	0.00132	CcSEcCtD
Plerixafor—Insomnia—Hydrocortisone—atopic dermatitis	0.000664	0.00131	CcSEcCtD
Plerixafor—Paraesthesia—Hydrocortisone—atopic dermatitis	0.000659	0.00131	CcSEcCtD
Plerixafor—Discomfort—Betamethasone—atopic dermatitis	0.000646	0.00128	CcSEcCtD
Plerixafor—Discomfort—Dexamethasone—atopic dermatitis	0.000646	0.00128	CcSEcCtD
Plerixafor—Dyspepsia—Hydrocortisone—atopic dermatitis	0.000646	0.00128	CcSEcCtD
Plerixafor—Pain—Prednisolone—atopic dermatitis	0.000643	0.00127	CcSEcCtD
Plerixafor—Gastrointestinal disorder—Hydrocortisone—atopic dermatitis	0.000634	0.00125	CcSEcCtD
Plerixafor—Fatigue—Hydrocortisone—atopic dermatitis	0.000633	0.00125	CcSEcCtD
Plerixafor—CXCR4—Signaling by GPCR—CCR5—atopic dermatitis	0.00063	0.00127	CbGpPWpGaD
Plerixafor—Musculoskeletal discomfort—Triamcinolone—atopic dermatitis	0.00063	0.00125	CcSEcCtD
Plerixafor—Musculoskeletal discomfort—Methylprednisolone—atopic dermatitis	0.000628	0.00124	CcSEcCtD
Plerixafor—Pain—Hydrocortisone—atopic dermatitis	0.000628	0.00124	CcSEcCtD
Plerixafor—Anaphylactic shock—Betamethasone—atopic dermatitis	0.000627	0.00124	CcSEcCtD
Plerixafor—Anaphylactic shock—Dexamethasone—atopic dermatitis	0.000627	0.00124	CcSEcCtD
Plerixafor—Insomnia—Triamcinolone—atopic dermatitis	0.000625	0.00124	CcSEcCtD
Plerixafor—Insomnia—Methylprednisolone—atopic dermatitis	0.000624	0.00124	CcSEcCtD
Plerixafor—Ill-defined disorder—Prednisone—atopic dermatitis	0.000621	0.00123	CcSEcCtD
Plerixafor—Paraesthesia—Triamcinolone—atopic dermatitis	0.000621	0.00123	CcSEcCtD
Plerixafor—Feeling abnormal—Prednisolone—atopic dermatitis	0.000619	0.00123	CcSEcCtD
Plerixafor—Paraesthesia—Methylprednisolone—atopic dermatitis	0.000619	0.00123	CcSEcCtD
Plerixafor—Shock—Dexamethasone—atopic dermatitis	0.000617	0.00122	CcSEcCtD
Plerixafor—Shock—Betamethasone—atopic dermatitis	0.000617	0.00122	CcSEcCtD
Plerixafor—Dyspnoea—Triamcinolone—atopic dermatitis	0.000616	0.00122	CcSEcCtD
Plerixafor—Nervous system disorder—Dexamethasone—atopic dermatitis	0.000615	0.00122	CcSEcCtD
Plerixafor—Nervous system disorder—Betamethasone—atopic dermatitis	0.000615	0.00122	CcSEcCtD
Plerixafor—Dyspepsia—Triamcinolone—atopic dermatitis	0.000608	0.0012	CcSEcCtD
Plerixafor—Dyspepsia—Methylprednisolone—atopic dermatitis	0.000607	0.0012	CcSEcCtD
Plerixafor—Hyperhidrosis—Betamethasone—atopic dermatitis	0.000606	0.0012	CcSEcCtD
Plerixafor—Hyperhidrosis—Dexamethasone—atopic dermatitis	0.000606	0.0012	CcSEcCtD
Plerixafor—CXCR4—Signaling Pathways—TAC1—atopic dermatitis	0.000605	0.00122	CbGpPWpGaD
Plerixafor—CXCR4—Signaling Pathways—NPS—atopic dermatitis	0.000605	0.00122	CbGpPWpGaD
Plerixafor—Feeling abnormal—Hydrocortisone—atopic dermatitis	0.000605	0.0012	CcSEcCtD
Plerixafor—Malaise—Prednisone—atopic dermatitis	0.000604	0.0012	CcSEcCtD
Plerixafor—Gastrointestinal pain—Hydrocortisone—atopic dermatitis	0.0006	0.00119	CcSEcCtD
Plerixafor—Syncope—Prednisone—atopic dermatitis	0.0006	0.00119	CcSEcCtD
Plerixafor—Urticaria—Prednisolone—atopic dermatitis	0.000597	0.00118	CcSEcCtD
Plerixafor—Fatigue—Triamcinolone—atopic dermatitis	0.000596	0.00118	CcSEcCtD
Plerixafor—Fatigue—Methylprednisolone—atopic dermatitis	0.000595	0.00118	CcSEcCtD
Plerixafor—CXCR4—Signaling Pathways—CXCR3—atopic dermatitis	0.000594	0.0012	CbGpPWpGaD
Plerixafor—Pain—Triamcinolone—atopic dermatitis	0.000591	0.00117	CcSEcCtD
Plerixafor—Loss of consciousness—Prednisone—atopic dermatitis	0.000588	0.00116	CcSEcCtD
Plerixafor—Urticaria—Hydrocortisone—atopic dermatitis	0.000583	0.00115	CcSEcCtD
Plerixafor—Abdominal pain—Hydrocortisone—atopic dermatitis	0.00058	0.00115	CcSEcCtD
Plerixafor—Musculoskeletal discomfort—Dexamethasone—atopic dermatitis	0.000571	0.00113	CcSEcCtD
Plerixafor—Musculoskeletal discomfort—Betamethasone—atopic dermatitis	0.000571	0.00113	CcSEcCtD
Plerixafor—Arthralgia—Prednisone—atopic dermatitis	0.00057	0.00113	CcSEcCtD
Plerixafor—Feeling abnormal—Triamcinolone—atopic dermatitis	0.00057	0.00113	CcSEcCtD
Plerixafor—Feeling abnormal—Methylprednisolone—atopic dermatitis	0.000568	0.00113	CcSEcCtD
Plerixafor—Insomnia—Betamethasone—atopic dermatitis	0.000567	0.00112	CcSEcCtD
Plerixafor—Insomnia—Dexamethasone—atopic dermatitis	0.000567	0.00112	CcSEcCtD
Plerixafor—Unspecified disorder of skin and subcutaneous tissue—Prednisone—atopic dermatitis	0.000566	0.00112	CcSEcCtD
Plerixafor—Gastrointestinal pain—Methylprednisolone—atopic dermatitis	0.000564	0.00112	CcSEcCtD
Plerixafor—Paraesthesia—Dexamethasone—atopic dermatitis	0.000563	0.00112	CcSEcCtD
Plerixafor—Paraesthesia—Betamethasone—atopic dermatitis	0.000563	0.00112	CcSEcCtD
Plerixafor—Discomfort—Prednisone—atopic dermatitis	0.000563	0.00111	CcSEcCtD
Plerixafor—CXCR4—Signaling Pathways—IL5—atopic dermatitis	0.000563	0.00114	CbGpPWpGaD
Plerixafor—Hypersensitivity—Prednisolone—atopic dermatitis	0.000554	0.0011	CcSEcCtD
Plerixafor—Dyspepsia—Dexamethasone—atopic dermatitis	0.000552	0.00109	CcSEcCtD
Plerixafor—Dyspepsia—Betamethasone—atopic dermatitis	0.000552	0.00109	CcSEcCtD
Plerixafor—Urticaria—Triamcinolone—atopic dermatitis	0.000549	0.00109	CcSEcCtD
Plerixafor—Urticaria—Methylprednisolone—atopic dermatitis	0.000548	0.00108	CcSEcCtD
Plerixafor—Anaphylactic shock—Prednisone—atopic dermatitis	0.000546	0.00108	CcSEcCtD
Plerixafor—Abdominal pain—Methylprednisolone—atopic dermatitis	0.000545	0.00108	CcSEcCtD
Plerixafor—Gastrointestinal disorder—Dexamethasone—atopic dermatitis	0.000541	0.00107	CcSEcCtD
Plerixafor—Gastrointestinal disorder—Betamethasone—atopic dermatitis	0.000541	0.00107	CcSEcCtD
Plerixafor—Hypersensitivity—Hydrocortisone—atopic dermatitis	0.000541	0.00107	CcSEcCtD
Plerixafor—Fatigue—Betamethasone—atopic dermatitis	0.000541	0.00107	CcSEcCtD
Plerixafor—Fatigue—Dexamethasone—atopic dermatitis	0.000541	0.00107	CcSEcCtD
Plerixafor—Shock—Prednisone—atopic dermatitis	0.000537	0.00106	CcSEcCtD
Plerixafor—Pain—Dexamethasone—atopic dermatitis	0.000536	0.00106	CcSEcCtD
Plerixafor—Pain—Betamethasone—atopic dermatitis	0.000536	0.00106	CcSEcCtD
Plerixafor—Nervous system disorder—Prednisone—atopic dermatitis	0.000536	0.00106	CcSEcCtD
Plerixafor—CXCR4—Disease—CCR5—atopic dermatitis	0.000531	0.00107	CbGpPWpGaD
Plerixafor—Skin disorder—Prednisone—atopic dermatitis	0.000531	0.00105	CcSEcCtD
Plerixafor—Hyperhidrosis—Prednisone—atopic dermatitis	0.000528	0.00105	CcSEcCtD
Plerixafor—Asthenia—Hydrocortisone—atopic dermatitis	0.000527	0.00104	CcSEcCtD
Plerixafor—Pruritus—Hydrocortisone—atopic dermatitis	0.000519	0.00103	CcSEcCtD
Plerixafor—Feeling abnormal—Betamethasone—atopic dermatitis	0.000517	0.00102	CcSEcCtD
Plerixafor—Feeling abnormal—Dexamethasone—atopic dermatitis	0.000517	0.00102	CcSEcCtD
Plerixafor—Gastrointestinal pain—Betamethasone—atopic dermatitis	0.000513	0.00102	CcSEcCtD
Plerixafor—Gastrointestinal pain—Dexamethasone—atopic dermatitis	0.000513	0.00102	CcSEcCtD
Plerixafor—Hypersensitivity—Triamcinolone—atopic dermatitis	0.000509	0.00101	CcSEcCtD
Plerixafor—Hypersensitivity—Methylprednisolone—atopic dermatitis	0.000508	0.00101	CcSEcCtD
Plerixafor—Diarrhoea—Hydrocortisone—atopic dermatitis	0.000502	0.000995	CcSEcCtD
Plerixafor—Urticaria—Betamethasone—atopic dermatitis	0.000498	0.000987	CcSEcCtD
Plerixafor—Urticaria—Dexamethasone—atopic dermatitis	0.000498	0.000987	CcSEcCtD
Plerixafor—Musculoskeletal discomfort—Prednisone—atopic dermatitis	0.000498	0.000985	CcSEcCtD
Plerixafor—Dizziness—Prednisolone—atopic dermatitis	0.000497	0.000984	CcSEcCtD
Plerixafor—Asthenia—Triamcinolone—atopic dermatitis	0.000496	0.000982	CcSEcCtD
Plerixafor—Abdominal pain—Betamethasone—atopic dermatitis	0.000496	0.000982	CcSEcCtD
Plerixafor—Abdominal pain—Dexamethasone—atopic dermatitis	0.000496	0.000982	CcSEcCtD
Plerixafor—Asthenia—Methylprednisolone—atopic dermatitis	0.000495	0.00098	CcSEcCtD
Plerixafor—Insomnia—Prednisone—atopic dermatitis	0.000494	0.000978	CcSEcCtD
Plerixafor—Paraesthesia—Prednisone—atopic dermatitis	0.00049	0.000971	CcSEcCtD
Plerixafor—Pruritus—Triamcinolone—atopic dermatitis	0.000489	0.000968	CcSEcCtD
Plerixafor—Pruritus—Methylprednisolone—atopic dermatitis	0.000488	0.000966	CcSEcCtD
Plerixafor—Dizziness—Hydrocortisone—atopic dermatitis	0.000485	0.000961	CcSEcCtD
Plerixafor—Dyspepsia—Prednisone—atopic dermatitis	0.000481	0.000952	CcSEcCtD
Plerixafor—CXCR4—Signaling Pathways—CXCL10—atopic dermatitis	0.00048	0.00097	CbGpPWpGaD
Plerixafor—Rash—Prednisolone—atopic dermatitis	0.000474	0.000938	CcSEcCtD
Plerixafor—Dermatitis—Prednisolone—atopic dermatitis	0.000474	0.000938	CcSEcCtD
Plerixafor—Diarrhoea—Methylprednisolone—atopic dermatitis	0.000472	0.000934	CcSEcCtD
Plerixafor—Fatigue—Prednisone—atopic dermatitis	0.000471	0.000932	CcSEcCtD
Plerixafor—Headache—Prednisolone—atopic dermatitis	0.000471	0.000932	CcSEcCtD
Plerixafor—Constipation—Prednisone—atopic dermatitis	0.000467	0.000925	CcSEcCtD
Plerixafor—Vomiting—Hydrocortisone—atopic dermatitis	0.000467	0.000924	CcSEcCtD
Plerixafor—Rash—Hydrocortisone—atopic dermatitis	0.000463	0.000917	CcSEcCtD
Plerixafor—Dermatitis—Hydrocortisone—atopic dermatitis	0.000462	0.000916	CcSEcCtD
Plerixafor—Headache—Hydrocortisone—atopic dermatitis	0.00046	0.000911	CcSEcCtD
Plerixafor—Dizziness—Triamcinolone—atopic dermatitis	0.000457	0.000905	CcSEcCtD
Plerixafor—Dizziness—Methylprednisolone—atopic dermatitis	0.000456	0.000903	CcSEcCtD
Plerixafor—Feeling abnormal—Prednisone—atopic dermatitis	0.00045	0.000891	CcSEcCtD
Plerixafor—Asthenia—Dexamethasone—atopic dermatitis	0.00045	0.000891	CcSEcCtD
Plerixafor—Asthenia—Betamethasone—atopic dermatitis	0.00045	0.000891	CcSEcCtD
Plerixafor—Gastrointestinal pain—Prednisone—atopic dermatitis	0.000447	0.000884	CcSEcCtD
Plerixafor—Nausea—Prednisolone—atopic dermatitis	0.000446	0.000884	CcSEcCtD
Plerixafor—Pruritus—Dexamethasone—atopic dermatitis	0.000444	0.000879	CcSEcCtD
Plerixafor—Pruritus—Betamethasone—atopic dermatitis	0.000444	0.000879	CcSEcCtD
Plerixafor—Vomiting—Triamcinolone—atopic dermatitis	0.00044	0.00087	CcSEcCtD
Plerixafor—Vomiting—Methylprednisolone—atopic dermatitis	0.000439	0.000868	CcSEcCtD
Plerixafor—Nausea—Hydrocortisone—atopic dermatitis	0.000436	0.000863	CcSEcCtD
Plerixafor—Rash—Triamcinolone—atopic dermatitis	0.000436	0.000863	CcSEcCtD
Plerixafor—Dermatitis—Triamcinolone—atopic dermatitis	0.000435	0.000862	CcSEcCtD
Plerixafor—Rash—Methylprednisolone—atopic dermatitis	0.000435	0.000861	CcSEcCtD
Plerixafor—Dermatitis—Methylprednisolone—atopic dermatitis	0.000434	0.00086	CcSEcCtD
Plerixafor—Urticaria—Prednisone—atopic dermatitis	0.000434	0.000859	CcSEcCtD
Plerixafor—Headache—Triamcinolone—atopic dermatitis	0.000433	0.000857	CcSEcCtD
Plerixafor—Headache—Methylprednisolone—atopic dermatitis	0.000432	0.000856	CcSEcCtD
Plerixafor—Abdominal pain—Prednisone—atopic dermatitis	0.000432	0.000855	CcSEcCtD
Plerixafor—Diarrhoea—Dexamethasone—atopic dermatitis	0.000429	0.00085	CcSEcCtD
Plerixafor—Diarrhoea—Betamethasone—atopic dermatitis	0.000429	0.00085	CcSEcCtD
Plerixafor—CXCR4—GPCR downstream signaling—CXCL8—atopic dermatitis	0.000419	0.000847	CbGpPWpGaD
Plerixafor—Dizziness—Betamethasone—atopic dermatitis	0.000415	0.000821	CcSEcCtD
Plerixafor—Dizziness—Dexamethasone—atopic dermatitis	0.000415	0.000821	CcSEcCtD
Plerixafor—CXCR4—Signaling Pathways—CCL5—atopic dermatitis	0.000413	0.000835	CbGpPWpGaD
Plerixafor—Nausea—Triamcinolone—atopic dermatitis	0.000411	0.000813	CcSEcCtD
Plerixafor—Nausea—Methylprednisolone—atopic dermatitis	0.00041	0.000811	CcSEcCtD
Plerixafor—Hypersensitivity—Prednisone—atopic dermatitis	0.000402	0.000797	CcSEcCtD
Plerixafor—CXCR4—GPCR downstream signaling—IL2—atopic dermatitis	0.000401	0.00081	CbGpPWpGaD
Plerixafor—Vomiting—Dexamethasone—atopic dermatitis	0.000399	0.00079	CcSEcCtD
Plerixafor—Vomiting—Betamethasone—atopic dermatitis	0.000399	0.00079	CcSEcCtD
Plerixafor—Rash—Dexamethasone—atopic dermatitis	0.000395	0.000783	CcSEcCtD
Plerixafor—Rash—Betamethasone—atopic dermatitis	0.000395	0.000783	CcSEcCtD
Plerixafor—Dermatitis—Dexamethasone—atopic dermatitis	0.000395	0.000782	CcSEcCtD
Plerixafor—Dermatitis—Betamethasone—atopic dermatitis	0.000395	0.000782	CcSEcCtD
Plerixafor—Headache—Dexamethasone—atopic dermatitis	0.000393	0.000778	CcSEcCtD
Plerixafor—Headache—Betamethasone—atopic dermatitis	0.000393	0.000778	CcSEcCtD
Plerixafor—Asthenia—Prednisone—atopic dermatitis	0.000392	0.000776	CcSEcCtD
Plerixafor—Pruritus—Prednisone—atopic dermatitis	0.000386	0.000765	CcSEcCtD
Plerixafor—CXCR4—Signaling Pathways—NGF—atopic dermatitis	0.000383	0.000773	CbGpPWpGaD
Plerixafor—CXCR4—Signaling by GPCR—CXCL8—atopic dermatitis	0.000381	0.00077	CbGpPWpGaD
Plerixafor—Diarrhoea—Prednisone—atopic dermatitis	0.000374	0.00074	CcSEcCtD
Plerixafor—Nausea—Dexamethasone—atopic dermatitis	0.000373	0.000738	CcSEcCtD
Plerixafor—Nausea—Betamethasone—atopic dermatitis	0.000373	0.000738	CcSEcCtD
Plerixafor—CXCR4—Signaling Pathways—CCR5—atopic dermatitis	0.000372	0.000752	CbGpPWpGaD
Plerixafor—CXCR4—Signaling by GPCR—IL2—atopic dermatitis	0.000364	0.000735	CbGpPWpGaD
Plerixafor—Dizziness—Prednisone—atopic dermatitis	0.000361	0.000715	CcSEcCtD
Plerixafor—Vomiting—Prednisone—atopic dermatitis	0.000347	0.000688	CcSEcCtD
Plerixafor—Rash—Prednisone—atopic dermatitis	0.000344	0.000682	CcSEcCtD
Plerixafor—Dermatitis—Prednisone—atopic dermatitis	0.000344	0.000681	CcSEcCtD
Plerixafor—Headache—Prednisone—atopic dermatitis	0.000342	0.000678	CcSEcCtD
Plerixafor—CXCR4—Disease—CD4—atopic dermatitis	0.000334	0.000674	CbGpPWpGaD
Plerixafor—Nausea—Prednisone—atopic dermatitis	0.000324	0.000642	CcSEcCtD
Plerixafor—CXCR4—Signaling Pathways—NFKBIA—atopic dermatitis	0.000316	0.000637	CbGpPWpGaD
Plerixafor—CXCR4—Signaling Pathways—CXCL8—atopic dermatitis	0.000225	0.000455	CbGpPWpGaD
Plerixafor—CXCR4—Signaling Pathways—IL2—atopic dermatitis	0.000215	0.000434	CbGpPWpGaD
Plerixafor—CXCR4—Signaling by GPCR—IL6—atopic dermatitis	0.000214	0.000432	CbGpPWpGaD
Plerixafor—CXCR4—Signaling Pathways—MAPK8—atopic dermatitis	0.000198	0.0004	CbGpPWpGaD
Plerixafor—CXCR4—Disease—IL6—atopic dermatitis	0.000181	0.000365	CbGpPWpGaD
Plerixafor—CXCR4—Signaling Pathways—IL6—atopic dermatitis	0.000126	0.000255	CbGpPWpGaD
